Blog
FDA Tightens the Belt on GLP-1 Compounding, Escalating Threat of Enforcement
Key Takeaways : On Feb. 6, 2026, FDA announced that it would take action to restrict access to GLP-1 ingredients for non-FDA approved compounded drugs….
By: Polsinelli